PI3 Kinase p110α Recombinant Rabbit Monoclonal Antibody [SJ0186]
Catalog# ET1606-36
PI3 Kinase p110α Recombinant Rabbit Monoclonal Antibody [SJ0186]
-
WB
-
IF-Cell
-
IF-Tissue
-
IP
-
IHC-P
-
Human
-
Mouse
-
unconjugated
Overview
Product Name
PI3 Kinase p110α Recombinant Rabbit Monoclonal Antibody [SJ0186]
Antibody Type
Recombinant Rabbit monoclonal Antibody
Immunogen
Synthetic peptide within Human PIK3CA aa 1,001-1,050 / 1,068.
Species Reactivity
Human, Mouse
Validated Applications
WB, IF-Cell, IF-Tissue, IP, IHC-P
Molecular Weight
Predicted band size: 124 kDa
Positive Control
HepG2 cell lysate, Hela cell lysate, Jurkat cell lysate, NIH/3T3 cell lysate, mouse brain tissue lysate, mouse liver tissue lysate, HepG2 cells, Hela cells, MCF-7 cells, human brain tissue, human liver tissue, mouse liver tissue.
Conjugation
unconjugated
Clone Number
SJ0186
RRID
Product Features
Form
Liquid
Concentration
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). It is recommended to aliquot into single-use upon delivery. Store at -20℃ long term.
Storage Buffer
1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgG
Purification Method
Protein A affinity purified.
Application Dilution
-
WB
-
1:1,000
-
IF-Cell
-
1:50-1:200
-
IF-Tissue
-
1:50-1:200
-
IP
-
1-2μg/sample
-
IHC-P
-
1:50-1:200
Target
Function
Phosphoinositide-3-kinase (PI3K) phosphorylates phosphatidylinositol (PI) and its phosphorylated derivatives at position 3 of the inositol ring to produce 3-phosphoinositides. Uses ATP and PtdIns(4,5)P2 (phosphatidylinositol 4,5-bisphosphate) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3). PIP3 plays a key role by recruiting PH domain-containing proteins to the membrane, including AKT1 and PDPK1, activating signaling cascades involved in cell growth, survival, proliferation, motility and morphology. Participates in cellular signaling in response to various growth factors. Involved in the activation of AKT1 upon stimulation by receptor tyrosine kinases ligands such as EGF, insulin, IGF1, VEGFA and PDGF. Involved in signaling via insulin-receptor substrate (IRS) proteins. Essential in endothelial cell migration during vascular development through VEGFA signaling, possibly by regulating RhoA activity. Required for lymphatic vasculature development, possibly by binding to RAS and by activation by EGF and FGF2, but not by PDGF. Regulates invadopodia formation through the PDPK1-AKT1 pathway. Participates in cardiomyogenesis in embryonic stem cells through a AKT1 pathway. Participates in vasculogenesis in embryonic stem cells through PDK1 and protein kinase C pathway. In addition to its lipid kinase activity, it displays a serine-protein kinase activity that results in the autophosphorylation of the p85alpha regulatory subunit as well as phosphorylation of other proteins such as 4EBP1, H-Ras, the IL-3 beta c receptor and possibly others. Plays a role in the positive regulation of phagocytosis and pinocytosis.
Background References
1. Salm, F. et al. 2015. The Phosphoinositide 3-Kinase p110α Isoform Regulates Leukemia Inhibitory Factor Receptor Expression via c-Myc and miR-125b to Promote Cell Proliferation in Medulloblastoma. PloS one. 10: e0123958.
2. Akula, M.K. et al. 2016. Control of the innate immune response by the mevalonate pathway. Nature immunology. 17: 922-9.
Sequence Similarity
Belongs to the PI3/PI4-kinase family.
Subcellular Location
Cytosol, plasma membrane, cytoplasm, lamellipodium, membrane, phosphatidylinositol 3-kinase complex, phosphatidylinositol 3-kinase complex, class IA.
Synonyms
5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha antibody
5-bisphosphate 3-kinase catalytic subunit alpha isoform antibody
caPI3K antibody
CLOVE antibody
CWS5 antibody
MCAP antibody
MCM antibody
MCMTC antibody
MGC142161 antibody
MGC142163 antibody
Expand5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha antibody
5-bisphosphate 3-kinase catalytic subunit alpha isoform antibody
caPI3K antibody
CLOVE antibody
CWS5 antibody
MCAP antibody
MCM antibody
MCMTC antibody
MGC142161 antibody
MGC142163 antibody
p110 alpha antibody
p110alpha antibody
Phosphatidylinositol 3 kinase catalytic alpha polypeptide antibody
Phosphatidylinositol 3 kinase catalytic 110 KD alpha antibody
Phosphatidylinositol 4 5 bisphosphate 3 kinase catalytic subunit alpha antibody
Phosphatidylinositol 4 5 bisphosphate 3 kinase catalytic subunit alpha isoform antibody
Phosphatidylinositol 4,5 bisphosphate 3 kinase 110 kDa catalytic subunit alpha antibody
Phosphatidylinositol-4 antibody
Phosphoinositide 3 kinase catalytic alpha polypeptide antibody
PI3 kinase p110 subunit alpha antibody
PI3-kinase subunit alpha antibody
PI3K antibody
PI3K-alpha antibody
PI3KC A antibody
PIK3C A antibody
Pik3ca antibody
PK3CA antibody
PK3CA_HUMAN antibody
PtdIns 3 kinase p110 antibody
PtdIns-3-kinase subunit alpha antibody
PtdIns-3-kinase subunit p110-alpha antibody
Serine/threonine protein kinase PIK3CA antibody
CollapseImages
-
Western blot analysis of PI3 Kinase p110α on different lysates with Rabbit anti-PI3 Kinase p110α antibody (ET1606-36) at 1/1,000 dilution.
Lane 1: HepG2 cell lysate
Lane 2: Hela cell lysate
Lane 3: Jurkat cell lysate
Lane 4: NIH/3T3 cell lysate
Lane 5: mouse brain tissue lysate(20 µg/Lane)
Lane 6: mouse liver tissue lysate(20 µg/Lane)
Lysates/proteins at 10 µg/Lane.
Predicted band size: 124 kDa
Observed band size: 110 kDa
Exposure time: 3 minutes;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1606-36) at 1/1,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
ICC staining of PI3 Kinase p110α in HepG2 cells (green). Formalin fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 10 minutes at room temperature and blocked with 1% Blocker BSA for 15 minutes at room temperature. Cells were probed with the primary antibody (ET1606-36, 1/50) for 1 hour at room temperature, washed with PBS. Alexa Fluor®488 Goat anti-Rabbit IgG was used as the secondary antibody at 1/1,000 dilution. The nuclear counter stain is DAPI (blue).
-
ICC staining of PI3 Kinase p110α in Hela cells (green). Formalin fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 10 minutes at room temperature and blocked with 1% Blocker BSA for 15 minutes at room temperature. Cells were probed with the primary antibody (ET1606-36, 1/50) for 1 hour at room temperature, washed with PBS. Alexa Fluor®488 Goat anti-Rabbit IgG was used as the secondary antibody at 1/1,000 dilution. The nuclear counter stain is DAPI (blue).
-
ICC staining of PI3 Kinase p110α in MCF-7 cells (green). Formalin fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 10 minutes at room temperature and blocked with 1% Blocker BSA for 15 minutes at room temperature. Cells were probed with the primary antibody (ET1606-36, 1/50) for 1 hour at room temperature, washed with PBS. Alexa Fluor®488 Goat anti-Rabbit IgG was used as the secondary antibody at 1/1,000 dilution. The nuclear counter stain is DAPI (blue).
-
Immunohistochemical analysis of paraffin-embedded human brain tissue with Rabbit anti-PI3 Kinase p110α antibody (ET1606-36) at 1/50 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1606-36) at 1/50 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human liver tissue with Rabbit anti-PI3 Kinase p110α antibody (ET1606-36) at 1/50 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1606-36) at 1/50 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded mouse liver tissue with Rabbit anti-PI3 Kinase p110α antibody (ET1606-36) at 1/200 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1606-36) at 1/200 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
PI3 Kinase p110α was immunoprecipitated from 0.2 mg HeLa cell lysate with ET1606-36 at 2 µg/10 µl beads. Western blot was performed from the immunoprecipitate using ET1606-36 at 1/1,000 dilution. Anti-Rabbit IgG for IP Nano-secondary antibody (NBI01H) at 1/5,000 dilution was used for 1 hour at room temperature.
Lane 1: HeLa cell lysate (input)
Lane 2: ET1606-36 IP in HeLa cell lysate
Lane 3: Rabbit IgG instead of ET1606-36 in HeLa cell lysate
Blocking/Dilution buffer: 5% NFDM/TBST
Exposure time: 2 minutes; ECL: K1802
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Citation
-
Spatiotemporally Controllable In Situ Hydrogels Enabled by Nanobottle-Mediated Encapsulation Technology for Stage-Specific Synergistic Therapy of Osteoarthritis
Journal: Advanced Functional Materials
DOI: 10.1002/adfm.202531767
IF: 19
Application: WB
Reactivity: Rat
Publish date: 2026 Feb
-
Bifidobacterium longum subsp. longum B-53 Alleviated Abnormalities of Glycolipid Metabolism and Oxidative Stress in T2DM Mice Through Regulating Gut Microbiota and GLP-1 Secretion
Journal: Journal Of Agricultural And Food Chemistry
DOI: 10.1021/acs.jafc.5c07346
IF: 6.2
Application: WB
Reactivity: Mouse
Publish date: 2025 Sept
-
Network pharmacology and experimental validation uncover how Shoutai Pills improve ovarian function in postpartum depression following a secondary birth
Journal: Journal Of Ethnopharmacology
DOI: 10.1016/j.jep.2025.120668
IF: 5.4
Application: IHC,WB
Reactivity: Mouse
Publish date: 2025 Oct
-
Conjugating 10,11-Dimethoxy-camptothecin with an Integrin αvβ3-Targeting Peptide through a Triazine Linker for Targeted Tumor Treatment in Lung and Pancreatic Carcinoma
Journal: Journal Of Medicinal Chemistry
DOI: 10.1021/acs.jmedchem.5c02059
IF: 6.8
Application: WB
Reactivity: Human
Publish date: 2025 Nov
-
Therapeutic Effects and Mechanisms of Alcohol Extracts from Polygala fallax Hemsl on Endometriosis in Rats
Journal: Archives Of Biochemistry And Biophysics
DOI: 10.1016/j.abb.2025.110393
IF: 3.8
Application: WB
Reactivity: Rat
Publish date: 2025 Mar
-
Trimethylamine N-oxide (TMAO) treatment triggers premature ovarian insufficiency (POI) via the activation of mitochondrial pathway apoptosis in granulosa cells
Journal: FREE RADICAL BIOLOGY AND MEDICINE
DOI: 10.1016/j.freeradbiomed.2025.03.007
IF: 8.2
Application: WB
Reactivity: Mouse
Publish date: 2025 Mar
-
Exosomal SPRY4 from adipogenic BMSCs impairs angiogenesis via the PTPRB/TIE2/PI3K axis in Steroid-induced osteonecrosis of the femoral head
Journal: Stem Cell Research & Therapy
DOI: 10.1186/s13287-025-04505-0
IF: 7.3
Application: WB
Reactivity: Human
Publish date: 2025 Jul
-
ACAT1 inhibitor Avasimibe suppresses osteoclastogenesis and alleviates ovariectomy-induced bone loss via CKB/PI3K-AKT signaling
Journal: International Immunopharmacology
DOI: 10.1016/j.intimp.2025.115973
IF: 4.7
Application: WB
Reactivity: Mouse
Publish date: 2025 Dec
-
HIF-1α regulates the proliferation and differentiation of mouse cranial base sphenoid-occipital synchondrosis chondrocytes via PI3K/Akt signaling
Journal: Scientific Reports
DOI: 10.1038/s41598-025-11055-1
IF: 3.9
Application: WB
Reactivity: Mouse
Publish date: 2025 Aug
-
Integrating serum pharmacochemistry and network pharmacology to explore potential compounds and mechanisms of Alpiniae oxyphyllae fructus in the treatment of cellular senescence in diabetic kidney disease
Journal: Frontiers In Medicine
DOI: 10.3389/fmed.2024.1424644
IF: 3.1
Application: WB
Reactivity: Mouse
Publish date: 2024 Jul
-
Identification and Validation of FGF-Related Prognostic Signatures in Prostate Cancer
Journal: Disease Markers
DOI:
IF: 3.464
Application: IHC-P
Reactivity: Human
Publish date: 2023 Feb